Symbol: DRREDDY
Month: 2025-02
Start Price: ₹1204.95
End Price: ₹1116.50
12M Return: -7.34%
6M Return: -7.34%
3M Return: -7.34%
Volatility: 0.205
Sharpe Ratio: -4.818
Max Drawdown: -0.100
Peer Correlation (DIVISLAB): 0.3559
Peer Correlation (SUNPHARMA): 0.6154
Peer Correlation (HINDUNILVR): 0.0305
Average Peer Correlation: 0.3339

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Dr. Reddy's Laboratories (DRREDDY) has underperformed in the past 12 months, with a return of -7.34%. The stock's volatility is moderate at 0.205, and its Sharpe Ratio is -4.818, indicating that the negative returns are not justified by the level of risk taken. The Max Drawdown of -0.100 suggests that the stock has experienced a significant decline in value. Correlation analysis reveals that DRREDDY has a moderate positive correlation with DIVISLAB and SUNPHARMA, but a weak correlation with HINDUNILVR. The average peer correlation is 0.3339.

**Recommendation:**

Based on the analysis, I would suggest a **SELL** recommendation for DRREDDY. The stock's poor performance, high volatility, and low Sharpe Ratio indicate that it may not be a good investment opportunity at present. Additionally, the Max Drawdown suggests that the stock is prone to significant declines in value, which could result in further losses for investors. While the peer correlations are not extremely high, they do indicate some level of correlation with other stocks in the industry, which could further exacerbate the stock's volatility.